ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+1.18%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$254M
AUM Growth
+$254M
(+7.8%)
Cap. Flow
+$18.5M
Cap. Flow
% of AUM
7.29%
Top 10 Holdings %
Top 10 Hldgs %
43.68%
Holding
89
New
20
Increased
18
Reduced
11
Closed
35
Top Buys
| 1 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$9.64M |
| 2 |
Takeda Pharmaceutical
TAK
|
$8.77M |
| 3 |
SIEN
Sientra, Inc.
SIEN
|
$7.38M |
| 4 |
Humana
HUM
|
$7.38M |
| 5 |
Encompass Health
EHC
|
$7.27M |
Top Sells
| 1 |
Icon
ICLR
|
$13.8M |
| 2 |
Gilead Sciences
GILD
|
$10.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
$9.3M |
| 4 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
$6M |
| 5 |
Evolent Health
EVH
|
$5.27M |
Sector Composition
| 1 | Healthcare | 77.04% |
| 2 | Technology | 6.14% |
| 3 | Industrials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Takeda Pharmaceutical
TAK
$47.3B
| $16.5M | 6.51% | 932,967 +495,531 | +113% | +$8.77M |
|
2
Labcorp
LH
$23.1B
| $14.3M | 5.65% | 82,900 +38,031 | +85% | +$6.58M |
|
3
Zimmer Biomet
ZBH
$21B
| $12.9M | 5.09% | 109,632 +32,346 | +42% | +$3.81M |
|
|
WMGI
4
DELISTED
Wright Medical Group Inc
WMGI
| $11.1M | 4.37% | 371,979 +124,562 | +50% | +$3.71M |
|
|
RCM
5
DELISTED
R1 RCM Inc. Common Stock
RCM
| $10.5M | 4.12% | 830,809 +80,433 | +11% | +$1.01M |
|
6
Cigna
CI
$80.3B
| $9.7M | 3.83% | 61,590 -5,407 | -8% | -$852K |
|
|
PRAH
7
DELISTED
PRA Health Sciences, Inc.
PRAH
| $9.64M | 3.8% | +97,200 | New | +$9.64M |
|
|
IIN
8
DELISTED
IntriCon Corporation
IIN
| $9.11M | 3.59% | 389,795 -162,662 | -29% | -$3.8M |
|
|
OXFD
9
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $8.66M | 3.41% | 629,236 +526,643 | +513% | +$7.25M |
|
10
iRhythm Technologies
IRTC
$5.46B
| $8.18M | 3.23% | 103,448 +53,115 | +106% | +$4.2M |
|
|
SIEN
11
DELISTED
Sientra, Inc.
SIEN
| $7.92M | 3.12% | 1,285,855 +1,197,482 | +1,355% | +$7.38M |
|
|
12
Humana
HUM
$36.5B
| $7.38M | 2.91% | +27,797 | New | +$7.38M |
|
|
13
Encompass Health
EHC
$12.3B
| $7.27M | 2.87% | +114,801 | New | +$7.27M |
|
|
AVDR
14
DELISTED
Avedro, Inc Common Stock
AVDR
| $7.03M | 2.77% | 357,942 -84,047 | -19% | -$1.65M |
|
15
AtriCure
ATRC
$1.84B
| $6.54M | 2.58% | 219,038 -47,539 | -18% | -$1.42M |
|
|
VCRA
16
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $6.48M | 2.55% | 203,000 -187,887 | -48% | -$6M |
|
17
AbbVie
ABBV
$372B
| $6.47M | 2.55% | 89,008 +67,334 | +311% | +$4.9M |
|
18
Cencora
COR
$56.5B
| $6.27M | 2.47% | 73,503 -15,033 | -17% | -$1.28M |
|
|
XENT
19
DELISTED
Intersect ENT, Inc
XENT
| $6.16M | 2.43% | 270,561 +205,004 | +313% | +$4.67M |
|
20
HCA Healthcare
HCA
$94.5B
| $5.9M | 2.32% | 43,623 -16,452 | -27% | -$2.22M |
|
21
Sanofi
SNY
$121B
| $5.22M | 2.06% | +120,614 | New | +$5.22M |
|
22
AstraZeneca
AZN
$248B
| $5.15M | 2.03% | +124,859 | New | +$5.15M |
|
23
Dentsply Sirona
XRAY
$2.85B
| $4.83M | 1.91% | 82,813 +53,825 | +186% | +$3.14M |
|
24
Iovance Biotherapeutics
IOVA
$807M
| $4.25M | 1.67% | +173,238 | New | +$4.25M |
|
|
NVRO
25
DELISTED
NEVRO CORP.
NVRO
| $4.11M | 1.62% | +63,394 | New | +$4.11M |
|